Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05132803
Title TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers
Recruitment Not yet recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Indications

head and neck squamous cell carcinoma

anus cancer

cervical cancer

Therapies

TA-CIN

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.